• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
AVCJ
  • Exits

Valiant exits Japanese drug dispensary group

  • Maya Ando
  • 19 January 2011
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  

Valiant Partners Co., a SME-focused private equity firm, has exited its stake in portfolio company Hanshin Dispensing Pharmacy Co., a Kobe-based pharmacy chain operator. The fund sold its entire stake to a holding company owned by the Iwasaki family, founders of Hanshin Dispensing Pharmacy, and to several industry players. This transaction is relatively unique given the involvement of the portfolio company’s founders in finding additional trade buyers.

Reports out of the Nikkei claimed that Alfresa Holding Co., Ltd., Medipal Holdings Co., Ltd. and Toho Holdings were the new shareholders. A spokesman at Alfresa confirmed the details.

Valiant and the Iwasaki Family took Hanshin Dispensing Pharmacy private through an MBO in 2007. The Iwasaki Family and their holding company now together own a 50.1% controlling stake, which includes shares the family has held since the MBO. While Valiant declined to comment, it is understood that the remaining 49.9% was sold by the firm to the three pharmaceutical groups for JPY7 billion ($84.2 million).

The exit appears to have been well-planned before Valiant took control of the company through a TOB to delist the Hanshin Dispensing from JASDAQ in 2008. "The exit result was what we anticipated, though selling a controlling stake back to the founding family was not originally planned. That said, [the Iwasakis] expected to take a core position in terms of capital and management. We understand their ideas and tried to get agreement from the individual buyers before the exit was finalized," said a Valiant Partners executive.

The group also noted that they "worked with the founding members to reassess capital management, improve performance and improve human resource systems, which has led us to our end target." Sales for the fiscal year ending March 2011 are slated to hit JPY33 billion ($397 million).

From late 2006 to mid-2008, drug dispensary businesses became M&A targets by drugstore chain operators that were finally allowed to own them. Increased competition in the drugstore space had led to a proliferation of new chains. A report by Deloitte shows that the number of drugstore operators rose 300% from 2000 to 2008. Following the change in rules, many drugstores looked to expand their business operations by purchasing dispensary companies in an effort to capture market share. Industry watchers believe that there will be further activity in the industry as pharmaceutical companies look to buy up these new, larger groups.

The Iwasaki family established Hanshin Dispensing Pharmacy Co. in 1975 with one flagship store in Kobe. The company now operates 123 outlets with 1,078 employees.

 

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  
  • Topics
  • Exits
  • North Asia
  • Healthcare
  • Valiant Partners Co.

More on Exits

artificial-intelligence-ai-chip-semiconductor
China AI player Mobvoi files for Hong Kong IPO
  • Greater China
  • 07 Jun 2023
japan-tokyo-shibuya
Japan buyouts: Bucking the trend
  • North Asia
  • 06 Jun 2023
wind-turbine-cleantech
Deal focus: Goldman secures $1bn exit from India’s ReNew
  • South Asia
  • 05 Apr 2023
asia-map-globe
Asia GPs must get smarter on target selection, costs - Bain & Co
  • Exits
  • 28 Mar 2023

Latest News

world-hands-globe-climate-esg
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs
  • 10 November 2023
housing-house-home-mortgage
Singapore fintech start-up LXA gets $10m seed round

New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.

  • Southeast Asia
  • 10 November 2023
india-rupee-money-nbfc
India's InCred announces $60m round, claims unicorn status

Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”

  • South Asia
  • 10 November 2023
roller-mark-luke-finn
Insight leads $50m round for Australia's Roller

Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.

  • Australasia
  • 10 November 2023
Back to Top
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013